Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2001, p. 1043-1052, Vol. 45, No. 4
Department of Pathology and Laboratory
Medicine, University of British Columbia-St. Paul's Hospital,
Vancouver, British Columbia V6Z 1Y6, Canada
Received 2 June 2000/Returned for modification 30 August
2000/Accepted 24 January 2001
The 5' and 3' untranslated regions (UTRs) of coxsackievirus B3
(CVB3) RNA form highly ordered secondary structures that have been
confirmed to play important regulatory roles in viral cap-independent internal translation initiation and RNA replication. We previously demonstrated that deletions in different regions of the 5' UTR significantly reduced viral RNA translation and infectivity. Such observations suggested strongly that viral RNA translation and replication could be blocked if highly specific antisense
oligodeoxynucleotides (AS-ODNs) were applied to target crucial sites
within the 5' and 3' UTRs. In this study, seven phosphorothioate
AS-ODNs were synthesized, and the antiviral activity was evaluated by
Lipofectin transfection of HeLa cells with AS-ODNs followed by
infection of CVB3. Analysis by Western blotting, reverse
transcription-PCR, and viral plaque assay demonstrated that viral
protein synthesis, genome replication, and infectivity of CVB3 were
strongly inhibited by the AS-ODNs complementary to different regions of
the 5' and 3' UTRs. The most effective sites are located at the
proximate terminus of the 5' UTR (AS-1), the proximate terminus of the
3' UTR (AS-7), the core sequence of the internal ribosome entry site
(AS-2), and the translation initiation codon region (AS-4). These
AS-ODNs showed highly sequence-specific and dose-dependent inhibitory effects on both viral protein synthesis and RNA replication. It is
noteworthy that the highest inhibitory activities were obtained with
AS-1 and AS-7 targeting the termini of the 5' and 3' UTRs. The percent
inhibition values of AS-1 and AS-7 for CVB3 protein VP1 synthesis and
RNA replication were 70.6 and 79.6 for AS-1 and 73.7 and 79.7 for AS-7,
respectively. These data suggest that CVB3 infectivity can be inhibited
effectively by AS-ODNs.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.4.1043-1052.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Specific Inhibition of Coxsackievirus B3 Translation and
Replication by Phosphorothioate Antisense
Oligodeoxynucleotides
*
Corresponding author. Mailing address: Cardiovascular
Research Laboratory, University of British Columbia, St. Paul's
Hospital, 1081 Burrard St., Vancouver, British Columbia, Canada V6Z
1Y6. Phone: (604) 806-8200. Fax: (604) 806-8208. E-mail:
dyang{at}mrl.ubc.ca.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |